Topiramate 10370-0365-11

Package NDC

10370-0365-11

Manufacturer: Endo Usa, Inc.
Dosage Form: Capsule, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 24, 2023
Listing Expires: December 31, 2026
Application: ANDA205976

Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Topiramate	25 mg/1

Drug Class

Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]

Selected Package

10370-0365-11Selected

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-11)

Other packages for this product(1)

10370-0365-01

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-01)

View →